FDA Investigating Risk of Pancreatitis in Type 2 Diabetes Meds
The US Food and Drug Administration (FDA) is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of drugs called incretin mimetics.
Seeking Approval of New Diabetes Med
For many diabetes patients, diet and exercise alone isn't enough to control blood sugar levels. These patients need medications. And they may need more options. A new diabetes medication is at the start of the approval process.
Diabetes Rx Go Head-to-Head
With all the available treatment options for type 2 diabetes, it can be hard to tell which one is right for which patient. A recent study addressed this difficulty with a comparison of two medications.